Aortic Valve replAcement in eLective Patients From aOrtic Valve multiceNter Registry
- Conditions
- Aortic Valve Stenosis
- Interventions
- Procedure: Surgical Aortic Valve ReplacementProcedure: Transcutenous Aortic Valve Implantation
- Registration Number
- NCT05308173
- Lead Sponsor
- Nicolaus Copernicus University
- Brief Summary
Multicenter registry data analysis of aortic valve stenosis patients that underwent elective, isolated transcutaneous aortic valve implantation (TAVI) or surgical aortic valve replacement between 2015 and 2019. In TAVI group only transfemoral access was considered.
- Detailed Description
A retrospective analysis of the Multicenter Aortic Valve Registry patients operated between 2015 and 2019 in the three departments of cardiac surgery in Poland: the Medical University of Silesia in Katowice, Medical University in Gdańsk, and Poznań, University of Medical Science. Baseline clinical, procedural, and outcome data at follow-up were entered into prespecified electronic case report forms. Follow-up status was validated by personal contact or access to Polish National Health Fund. Patients with planned concomitant intervention on coronary arteries (by bypass grafting or percutaneous intervention), other valvular interventions, arrhythmia ablation, or left atrial appendage occlusion were excluded too. In TAVI group only femoral access was considered. For SAVR any tissue or mechanical valve implantation in an aortic position with sternotomy or minimal access was included.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2393
- Age >18 years
- Elective procedure
- Aortic valve replacement with means of TAVI or SAVR
- Concomitant procedures
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Surgical Aortic Valve Replacement Surgical Aortic Valve Replacement Surgically replaced aortic valve. Patients with planned concomitant bypass grafting other valvular interventions, arrhythmia ablation, or left atrial appendage occlusion were excluded. Any tissue or mechanical valve implantation in an aortic position with sternotomy or minimal access was included. Transcutaneous Aortic Valve Implantation Transcutenous Aortic Valve Implantation Transfemoral aortic valve implantation. Patients with a planned concomitant percutaneous coronary intervention were excluded
- Primary Outcome Measures
Name Time Method all-cause death up to 6 years death resulting from cardiovascular and non-cardiovascular causes
- Secondary Outcome Measures
Name Time Method